Skip to main content
Sirio Pharma Co., Ltd. logo

Sirio Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 300791 ISIN · CNE100003NB0 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,175 across all filing types
Latest filing 2026-01-11 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300791

About Sirio Pharma Co., Ltd.

https://www.siriopharma.com

Sirio Pharma Co., Ltd. is a global contract development and manufacturing organization (CDMO) specializing in dietary supplements and nutraceuticals. The company provides comprehensive services encompassing product formulation, manufacturing, and packaging. Its portfolio includes diverse delivery formats such as softgels, gummies, tablets, hard capsules, powders, and oral liquids. Sirio Pharma emphasizes innovation in delivery systems, offering specialized solutions like plant-based softgels and advanced probiotic formulations. The organization adheres to rigorous quality management systems and maintains multiple international certifications to meet global regulatory standards. Serving an international clientele, the company supports health and wellness brands through scalable production capacities and integrated supply chain solutions.

Recent filings

Filing Released Lang Actions
关于制定及修订公司于H股发行上市后适用的内部治理制度的公告
Governance Information Classification · 95% confidence The document is an announcement from the company regarding the formulation and revision of internal governance systems applicable after the company's H-share listing. It details new and revised governance policies and mentions approvals by the board and shareholders. The document does not contain financial statements or results, nor is it a report or presentation. It is a regulatory announcement about governance policies and internal rules. This fits the category of Governance Information (CGR). The document length is short and it is not a report publication announcement or certification. Therefore, the classification is CGR with high confidence.
2026-01-11 Chinese
独立董事专门会议工作细则（草案）（H股发行并上市后适用）
Governance Information Classification · 95% confidence The document is titled '独立董事专门会议工作细则' which translates to 'Rules of Procedure for Independent Directors' Special Meetings' of a company. It details the governance structure, meeting procedures, voting mechanisms, and responsibilities of independent directors. It references relevant laws and listing rules but does not contain financial data, earnings, audit results, or any report publication. It is a governance-related document outlining internal rules and practices for board members, specifically independent directors. Therefore, it fits the category of Governance Information (CGR). The document length is 3041 characters, which is relatively short but contains substantive governance content rather than an announcement or a brief notice.
2026-01-11 Chinese
提名委员会工作细则（草案）（H股发行并上市后适用）
Governance Information Classification · 100% confidence The document is titled '董事会提名委员会工作细则' which translates to 'Board Nomination Committee Working Rules'. It details the structure, responsibilities, procedures, and governance of the board nomination committee of the company. It includes sections on committee composition, duties, meeting procedures, decision-making processes, and confidentiality obligations. There is no financial data, earnings information, or regulatory filing content. The document is a governance-related internal rules document concerning board and management nomination and governance practices. Therefore, it fits best under the category of Governance Information (CGR). The document length is 4480 characters, which is sufficient for a detailed governance report rather than a brief announcement or notice.
2026-01-11 Chinese
总经理工作细则（草案）（H股发行并上市后适用）
Governance Information Classification · 95% confidence The document is titled '总经理工作细则' (General Manager Work Rules) and details the responsibilities, authority, and procedural rules for the company's general manager and senior management. It references company governance, legal compliance, and internal management structures. There is no financial data, no mention of financial results, no shareholder voting results, no audit information, no capital or financing updates, no legal proceedings, no merger or acquisition activity, and no regulatory filings or announcements. The document is a governance-related internal policy document outlining management roles and duties, consistent with governance information filings. It is not a report or announcement but a detailed governance framework document.
2026-01-11 Chinese
董事会议事规则（草案）（H股发行并上市后适用）
Governance Information Classification · 100% confidence The document is titled '董事会议事规则' which translates to 'Board Meeting Rules' or 'Rules of Procedure for the Board of Directors'. It details the organization, procedures, notification, conduct, voting, record-keeping, execution, and archival of board meetings for the company 仙乐健康科技股份有限公司. It references compliance with company law, securities law, listing rules, and company articles of association. The content is focused on governance practices and internal rules for the board rather than financial results, audit opinions, or shareholder meeting materials. There is no indication that this is an announcement or a report of a meeting, but rather a governance document outlining the board's operational rules. Therefore, the document fits best under Governance Information (CGR). The document length (6279 characters) supports it being a full governance report rather than a brief announcement.
2026-01-11 Chinese
关于就H股发行修订于H股发行上市后生效的《公司章程（草案）》及相关议事规则（草案）的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the revision of the company's Articles of Association and related rules following the issuance and listing of H shares. It includes references to board meeting resolutions and the submission of these revisions to the shareholders for approval. The document does not contain financial statements or detailed financial data, nor is it a full report. It is a regulatory announcement about governance documents and procedural changes related to the company's listing. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement about corporate governance changes and compliance with listing rules, not a full governance report or board/management change announcement.
2026-01-11 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.